CARBOGEN AMCIS, a subsidiary of Dishman Carbogen Amcis (DCAL.NS), and a global top-tier Contract Development and Manufacturing Organisation (CDMO), today announced the successful refinancing and enhancement of its credit facilities through the banking syndication led by UBS Switzerland AG. “The successful refinancing and enhancement of the syndicated credit facilities provides access to an additional CHF […]
Post Type Archives: News
LabVantage Solutions Awarded $22.3 Million U.S. Customs and Border Protection Contract to Deliver Next-Generation Forensic LIMS
LabVantage Solutions, Inc., a global provider of laboratory informatics solutions and services, today announced it has been awarded a contract by the U.S. Department of Homeland Security’s Customs and Border Protection (CBP) valued at up to $22.3 million over ten years. The agreement supports modernization of the agency’s Forensic Laboratory Information Management System (FLIMS) to […]
Eli Lilly Strikes Gene Therapy Deal with MeiraGTx
MeiraGTX, a clinical-stage genetic medicines company, announced a strategic collaboration deal with Eli Lilly and Company on November 10th, 2025. Lilly will pay up to $475 million, plus tiered royalties, for the worldwide exclusive rights to MeiraGTX’s AAV-AIPL1 program. AAV-AIPL1 is intended as a treatment for Leber congenital amaurosis 4, a severe inherited retinopathy that […]
FDA Appoints Richard Pazdur as CDER Director
FDA announced plans to appoint Richard Pazdur as head of the Center for Drug Evaluation and Research on November 11th, 2025. Pazdur, who has been with FDA since 1999 and currently serves as the head of the Oncology Center of Excellence (OCE), will succeed Dr. George Tidmarsh, who resigned earlier this month amid scrutiny concerning […]
AES Cleanroom Technology Expands Southeast Footprint with New Office in Research Triangle Park
AES Cleanroom Technology, an award-winning leader in modular cleanroom design and construction, has opened a new regional office in Research Triangle Park (RTP), reinforcing its commitment to serving the Southeast’s fast-growing life sciences, biotechnology, and advanced manufacturing sectors. The new office strengthens AES’s presence within North Carolina’s innovation corridor — one of the nation’s most […]
Novartis opens new radioligand therapy manufacturing facility in California as part of $23B US expansion plan
Novartis, a leading global innovative medicines company, announced the opening of a new 10,000-square-foot radioligand therapy (RLT) manufacturing facility in Carlsbad, California. This state-of-the-art site represents a key milestone in the company’s previously announced $23 billion investment in US infrastructure over the next five years. The opening of the Carlsbad manufacturing facility allows Novartis to […]
Johnson & Johnson Receives FDA Approval for Smoldering Multiple Myeloma Treatment
Johnson & Johnson announced FDA approval of Darzalex Faspro (daratumumab and hyaluronidase-fihj) as a single-agent treatment for adult patients with high-risk smoldering multiple myeloma (HR-SMM) on November 6th, 2025. According to a company press release, it is the first and only approved treatment for HR-SMM. FDA approval was based on findings from the AQUILA study, […]
Pfizer Inks New $10 Billion Acquisition Deal for Metsara
Metsara, the maker of blockbuster obesity drugs Ozempic and Wegovy, announced a new acquisition deal with Pfizer on November 7th, 2025. Pfizer will acquire Metsara for approximately $86.25 a share, or approximately $10 billion. This caps off a months-long dispute wherein Pfizer’s originally announced acquisition of Metsara was put into jeopardy after Novo Nordisk initiated […]
TRIMTECH Therapeutics appoints Dr Mike Hutton to Scientific Advisory Board
TRIMTECH Therapeutics, a biotech company creating novel, small molecule therapeutics that selectively degrade protein aggregates, to combat neurodegenerative diseases, today announced the appointment of Dr Mike Hutton to its Scientific Advisory Board (SAB). Mike will provide expert guidance to support the development of the Company’s targeted protein degradation (TPD) TRIMTAC™ and TRIMGLUE™ pipeline, including for […]
Abzena and Mabqi Announce Strategic Partnership to Offer Integrated Discovery through Development Solution
Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, and Mabqi, a biotechnology company focused on the discovery and development of fully human antibodies, announced the formation of a strategic partnership. This collaboration will integrate Mabqi’s antibody discovery capabilities with Abzena’s development and manufacturing services, offering biopharma customers a more streamlined, end-to-end drug […]